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It is clear that RNA is more than just a messenger between gene and protein. The mammalian genome is pervasively tran-
scribed, giving rise to tens of thousands of non-coding transcripts. Whether all of these transcripts are functional remains to be 
elucidated, but it is evident that there are many functional long non-coding RNAs (lncRNAs). Recent studies have set out to 
decode the regulatory role and functional diversity of lncRNAs. Here we organize these studies to highlight the significant in-
volvements of lncRNAs in regulation of gene expression and human physiological and pathological processes, which are 
achieved by their interaction with DNA, RNA or protein.  
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The great majority of mammalian genomes are potentially 
transcribed, the number of protein-coding genes, however, 
is fewer than initially anticipated and does not proportion-
ally increase with the increased genome complexity [1,2]. 
Transcripts from the non-coding genome, which lack the 
evident protein-coding potential and function in the form of 
RNA molecules, are referred to as non-coding RNAs 
(ncRNAs). ncRNAs can be arbitrarily classified into small 
ncRNAs, typically ~20200 nt in length, and long ncRNAs 
(lncRNAs), ranging from 200 nt to >100 kb [3]. Much evi-
dence on the significant role of small regulatory ncRNAs in 
gene expression has been widely accumulated [4], the re-
search on lncRNAs, however, is still in a beginning stage.  
Although the particular functions of lncRNAs still re-
main largely unclear, the appearance of their biological fea-
tures indicates that lncRNAs, at least a sizable fraction of 
them, are not inert in function. For example, lncRNAs 
lacking strong sequence conservation are highly conserved 
in their promoter regions; several lncRNAs are highly con-
served in secondary structure and possess conservative 
splice sites; some lncRNAs are only expressed in specific 
stages of tissue differentiation and development or present 
apparent tissue-specific expression patterns and distinct 
subcellular localizations [5,6]. Furthermore, increasing evi-
dence indicates that the dysregulation of lncRNAs is signif-
icantly involved in several types of diseases, including dif-
ferent types of cancer, Alzheimer’s disease, Huntington’s 
disease and cardiovascular diseases [711]. Altogether, we 
conclude that lncRNAs do not represent the “noise” of 
transcriptome, and the effort on decoding implication of 
lncRNAs in a variety of biological processes is expected to 
develop our knowledge on molecular biology to a newer 
frontier.  
1  Biological features of lncRNAs 
Many of the identified lncRNAs are transcribed by RNA 
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polymerase II (RNAP II) and placed into the cluster of 
mRNA-like transcripts. This type of mRNA-like lncRNAs 
bear many signatures of mRNAs, including 5′ capping, 
splicing, and poly-adenylation, but possess little or no open 
reading frame [12,13]. While the abundance of lncRNAs 
has been demonstrated by large-scale cDNA sequencing 
projects, which identified more than 35000 lncRNAs from 
the transcripts across the human genome [14], certain sub-
types of lncRNAs could be undervalued since the non-  
polyadenylated transcripts have been omitted. As expected, 
the following data from tiling array indicated that more than 
40% of transcripts are non-polyadenylated [15]. In addition, 
the identification of several RNAP III-produced lncRNAs 
further supports the opinion that the composition of 
lncRNAs is complicated. For instance, heat shock stimu-
lates RNAP III to drive the expression of human Alu RNAs 
(~300 nt) and mouse B2 RNA (217 nt) [16]. In contrast to 
abnormal physiology states that induce the confused ex-
pression of lncRNAs, the lower selective pressures under 
normal physiological conditions usually generate a strong 
cell type-specific expression of lncRNAs. In the latter case, 
the expression profiles of lncRNAs are generally more spe-
cific than that of protein-coding transcripts [14,17,18].  
To date, the origins of lncRNAs have been summarized 
as follows: (i) frame-disrupted transcription from protein- 
coding genes; (ii) chromosome recombination-facilitated 
locus throughout read; (iii) transposition effects from cer-
tain genetic elements such as retroposons; (iv) transcription 
of local tandem repeat sequences [19]. Based on the relative 
position with the protein-coding genes, lncRNAs could be 
further classified into the following five subtypes: (i) sense 
lncRNAs, sequences of which overlap with the sense strand 
of a protein-coding gene; (ii) antisense lncRNAs, which are 
expected to be transcribed from the antisense strand of a 
protein-coding gene; (iii) bidirectional lncRNAs, sequences 
of which are derived from the opposite strands of a pro-
tein-coding gene whose transcription start sites are located 
less than 1000 bp away; (iv) intronic lncRNAs, which are 
derived from the intronic region of a protein-coding gene; 
(v) intergenic lncRNAs, which are derived from the spacer 
of two separate protein-coding genes [19]. These classifica-
tion rules are thought to facilitate the interpretation, as well 
as the further investigation, on lncRNAs.  
Several studies have shown that specific lncRNAs are 
retained within the mammalian cell nucleus and are sug-
gested to play structural roles or act as riboregulators 
[18,2024]. The mammalian cell nucleus is compart-
mentalized into multiple non-membranous subnuclear do-
mains such as nucleoli, nuclear speckles, paraspeckles, Ca-
jal bodies and promyelocytic leukemia (PML) bodies, 
which in turn contain specific groups of proteins and RNAs 
involved in special nuclear processes [25,26]. With the re-
spective identification of NEAT1 RNA and NEAT2 RNA in 
paraspeckles and splicing speckles, it has been further sug-
gested that these nuclear-retained lncRNAs could play im-
portant function in a variety of gene-regulatory processes 
observed in multicellular organisms, especially the tran-
scriptional regulation and RNA metabolism [27].  
In contrast to the small regulatory ncRNAs such as 
miRNAs and endo-siRNAs that regulate gene expression 
mainly through the direct base pairing to target sites within 
untranslated regions of mRNAs, lncRNAs achieve their 
regulatory function through quite diverse strategies. It has 
been reported that GAS5 RNA serves as a false target of 
transcription factor GR to prevent the binding of GR to the 
promoter DNA [28]; an lncRNA derived from the second-
ary promoter of DHFR can bind in cis the primary promoter 
to form a DNA-RNA triplet, resulting in blocked recruit-
ment of TFIID, a transcriptional regulation cofactor, to the 
primary promoter and the subsequent transcription repres-
sion [29]; linc-MD1 RNA acts as miRNA sponge to sup-
press the activities of miR-133 and miR-135, resulting in 
increased levels of miRNA targets and the ultimate influ-
ence on muscle differentiation [30]. In conclusion, the ac-
cumulated studies show that lncRNAs not only serve as the 
precursors of certain small ncRNAs, such as miR-675 en-
coded by the H19 lncRNA [24,31], but also present a class 
of regulatory RNAs fundamentally distinct from the small 
ncRNAs, which appear to play roles through the mechanism 
of interaction with DNA, RNA or protein.  
2  Biological functions of lncRNAs 
A large range of biological processes including dosage 
compensation, imprinting, cell division and cell differentia-
tion are widely reported to be associated with lncRNAs, 
which are thought to work in cis on neighboring genes or in 
trans to regulate distantly located genes or molecular targets 
in nucleus and cytoplasm. In detail, lncRNAs can act as 
chromatin modifiers to influence the chromatin structure, as 
transcriptional regulators to affect the activities of transcrip-
tion factors or RNA polymerase, as modular scaffolds to 
recruit the assembly of multiple protein complexes, and as 
“false decoys” to sponge the coupled targets and thereby 
inhibit their correct cellular localization [3,19,3237]. Al-
together, the current studies suggest that lncRNAs could be 
involved in almost each step of gene expression, such as 
epigenetic regulation, transcriptional regulation and post- 
transcriptional regulation, through in cis or in trans manner, 
and the dysregulation of lncRNAs would cause broad 
changes in cell signaling pathways.     
2.1  lncRNAs in regulation of gene expression  
2.1.1  Epigenetic regulation  
Epigenetic regulation of gene expression, which is charac-
terized as the altered transcription without any change in 
gene sequence, is generally reported to play roles in organ-
ism development as well as tumorigenesis. Recently, the 
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involvement of lncRNAs in epigenetic regulation has been 
widely documented. Kcnq1ot1, a nuclear-retained lncRNA 
with the length of 91.5 kb, is transcribed by RNAPII from 
the intron 10 of Kcnq1 gene in an antisense orientation to 
Kcnq1 [38]. The production of Kcnq1ot1 RNA was first 
found to be associated with the lineage-specific silencing of 
dozens of genes within the Kcnq1 locus [38,39]. Recent 
studies further indicated that the silencing effects are 
achieved by the interactions of Kcnq1ot1 with chromatin 
and with the H3K9- and H3K27-specific histone methyl-
transferases G9a and the polycomb repressive complex 2 
(PRC2) [40]. HOTAIR and Air are the other two 
well-characterized lncRNAs involved in chromatin remod-
eling, which exert function through a similar fashion, in-
cluding accumulation at the chromatin regions of silenced 
alleles and the subsequent mediation of repressive histone 
modification through recruiting the specific chromatin 
modification complexes such as G9a, PRC1 and PRC2 
[4144]. Interestingly, another group reports that Kcnq1ot1 
RNA is also required for the maintenance of the silencing of 
ubiquitously imprinted genes (UIGs) through guiding and 
maintaining the CpG methylation at methylated regions 
flanking the UIGs [45]. Although the crosstalk between 
lncRNA-mediated DNA methylation and lncRNA-mediated 
histone modification remains to be elucidated, these studies 
highlight the significant involvement of lncRNAs in epige-
netic regulation of gene expression.  
2.1.2  Transcriptional regulation 
Transcription is a tightly regulated process in eukaryotes. In 
addition to the well-known factors such as RNA polymerase, 
general transcription factors and gene-specific transcription 
factors, it is also suggested that lncRNAs function in the 
complicated regulatory network to make gene expression 
more symphonic. Thus, a current central issue is to obtain a 
full understanding of the potential role of lncRNAs in regu-
lated gene transcription programs, possibly through diverse 
mechanisms.  
Through recruiting and modulating the activities of 
co-regulators, lncRNAs may act as selective ligands to pre-
vent the transcription of target genes. Wang et al. [46] re-
ported that DNA damage induces the production of several 
lncRNAs from the 5′ regulatory region of cyclin D1 
(CCND1). These induced lncRNAs specifically bind and 
allosterically modify TLS, a regulatory sensor of DNA 
damage, leading to the interaction of the modified TLS with 
CREB-binding protein (CBP) that thereby inhibits the tran-
scription of CCND1. Martianov et al. [29] reported another 
example of inhibitory lncRNA that is induced by serum 
starvation and functions as a promoter-specific transcrip-
tional repressor. Upon transcribed from the upstream minor 
promoter of DHFR gene, this lncRNA not only binds tran-
scription factor II B (TFIIB) to prevent its association with 
the major promoter, but also forms a stable complex with 
the major promoter that interferes in the promoter-directed 
recruitment of TFIIB.  
In addition to the inhibitory effect on transcription, 
lncRNAs could also act as activators or co-activators to 
upregulate gene expression. For instance, steroid receptor 
RNA activator (SRA) is an lncRNA transcript that acts as a 
eukaryotic transcriptional co-activator for steroid hormone 
receptors [47]. Another lncRNA, Evf-2, which is tran-
scribed from one of the two Dlx-5/6 conserved intergenic 
regions, activates transcriptional activity of homeodomain 
proteins by directly influencing Dlx-2 activity [48]. The 
functional importance of gene enhancers in regulated gene 
expression has been well established, and the subsequent 
identification of bidirectional lncRNAs transcribed from 
enhancers, termed as enhancer RNAs (eRNAs), adds anoth-
er functional layer to the transcriptional regulatory elements 
[4951]. A subtype of eRNAs, which are derived from en-
hancers adjacent to E2-upregulated coding genes, were ob-
served to contribute to E2-dependent gene activation by 
stabilizing E2/ER-/eRNA-induced enhancer-promoter loo- 
ping, suggesting that eRNAs are functional but not merely a 
reflection of enhancer activation [52].  
2.1.3  Post-transcriptional regulation 
One of the most versatile processing steps in the life of an 
mRNA molecule is pre-mRNA splicing, which provides a 
major source of transcriptome and proteome diversity in 
cells [53]. Although the spliceosome is required to perform 
splicing catalysis and additional splicing factors function in 
determining the splice sites, several recent studies have 
highlighted the significant role of lncRNAs in the regulation 
of pre-mRNA splicing. Depletion of MALAT1 RNA is re-
ported to compromise the recruitment of SR proteins from 
speckles to the sites of transcription, where splicing occurs 
[54]. Meanwhile, Tripathi et al. [55] indicate that MALAT1 
could act as a “molecular sponge” by interacting with SR 
proteins, especially SRSF1, in the nuclear speckles, and 
thereby modulate the concentration of splicing-competent 
SR proteins in cells. This “sponge” mechanism is also ap-
plicable to the untranslated region (UTR) of certain pro-
tein-coding genes. For instance, the repeat-containing RNA 
from the CTG expansion in 3′UTR of DMPK gene accumu-
lates in the nucleus and affects the activity of splicing fac-
tors. Similarly, CGG repeats occurred in FMR1 gene can 
recruit a set of splicing regulators into nuclear inclusions 
[56].  
miRNAs function as important post-transcriptional regu-
lators by triggering mRNA degradation or translational in-
hibition. Recently, miRNA activity has been proposed to be 
affected by some endogenous sponge transcripts that con-
tain the miRNA-matching sequence. For instance, in human 
and mouse brain, a highly expressed circular lncRNA, 
termed as ciRS-7, is reported to act as a miR-7 sponge. The 
sponge effect is mediated by the selectively conserved 
miRNA target sites contained in ciRS-7, which strongly 
suppress miR-7 activity and thereby result in increased lev-
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els of miR-7 targets [57]. In addition, identification of addi-
tional sponge lncRNAs, such as testis-specific Sry that tar-
gets miR-138, suggests that miRNA sponge effects could be 
a general phenomenon in organisms [30,5862].  
Furthermore, lncRNAs may also apply regulatory pres-
sure to other aspects of post-transcriptional regulation, such 
as RNA metabolism and translation [6366]. 
2.2  lncRNAs in tumorigenesis 
Comparison of gene expression profiles of tumor and nor-
mal cells has revealed a linkage of lncRNAs with tumori- 
genesis. For example, OCC-1 RNA is overexpressed in co-
lon cancer cells [67], and the overexpression of lncRNA 
PCEGEM1 could induce proliferation of cancer cells [68]. 
MALAT1 RNA is another documented metastasis-associated 
lncRNA, whose overexpression is associated with non- 
small cell lung cancer, breast cancer, colon cancer, prostatic 
cancer and liver cancer [69].  
Similar to miRNAs, lncRNAs can also serve as the po-
tential molecular targets for diagnosis and treatment of can-
cer. However, there are only limited studies decoding the 
detailed role of lncRNAs in tumorigenesis. Based on the 
ability to repress proto-oncogenes, PSF functions as a tu-
mor-suppressor protein, whose oncogenesis suppression 
activity, however, can be impaired by the enhancement of 
its RNA binding ability [70,71]. The subsequent studies 
identify several PSF-binding lncRNAs from mice and hu-
mans, which include retroposon-derived lncRNAs such as 
VL30 and frame-disrupted non-coding transcripts such as 
MALAT1. All the lncRNAs promote tumorigenesis in mice 
and humans through a mechanism of reversible regulation 
on proto-oncogene transcription, including the protein PSF 
that binds to the regulatory region of a proto-oncogene and 
represses transcription, and PSF-binding lncRNA that binds 
to PSF, forming a PSF-lncRNA complex that dissociates 
from a proto-oncogene, activating transcription [7276]. 
ANRIL and HOTAIR are two other tumorigenesis-related 
lncRNAs, which are discovered to recruit the PRC complex 
to locus in cis or specific target genes genome-wide, leading 
to histone methylation, epigenetic silencing of metastasis 
suppressor genes and increased tumor invasiveness and me-
tastasis [43,44,77].  
p53 is considered to be one of the most common denomi- 
nators in human cancer and plas a central role in regulatory 
networks responsible for cancer-related stress [7880]. It 
seems controversial to explain p53 pathway only from the 
perspective of protein-coding genes [8183]. As expected, a 
large number of miRNAs and conserved miRNA families 
are found to be direct transcriptional targets of p53 or func-
tion as the upstream regulators of p53 [84]. Several current 
studies further illustrate the linkage between lncRNAs and 
p53 pathway from the perspective of molecular biology. 
p53-activated lincRNA-p21 serves as a repressor, through 
interacting with heterogeneous nuclear ribonucleoprotein K 
(hnRNP-K), in p53-dependent transcriptional response. In-
hibition of lincRNA-p21 results in a global change in ex-
pression of hundreds of gene targets, a majority of which 
are downstream targets repressed by p53 and responsible for 
p53-mediated apoptosis [85]. Upon induced by p53, 
PANDA RNA interacts with transcription factor NF-YA to 
inhibit expression of proapoptosis genes, leading to cell 
cycle arrest [86]. Another study reports lncRNA RoR acts 
as an upstream p53 repressor in response to DNA damage. 
Unlike MDM2 that causes p53 degradation through the 
ubiquitin-proteasome pathway, RoR suppresses p53 transla-
tion through directly interacting with the hnRNP-I [87]. 
Collectively, these data reinforces the growing awareness 
that epigenetic regulation plays significant roles in tumor 
development by placing lncRNAs in the heartland of a 
well-known tumor-regulation network.  
2.3  lncRNAs in immune response and host defense 
Expression pattern of lncRNAs in cells is influenced by 
virus infection and lipopolysaccharide (LPS) stimulation 
[5,88]. NeST is the first lncRNA discovered in the immune 
system, which was showed to control susceptibility to 
Theiler’s virus and Salmonella infection in mice through 
epigenetic regulation of the IFN- locus [89,90]. The innate 
immune system coordinates host defenses through germ 
line-encoded pattern recognition receptors such as Toll-like 
receptors (TLRs), which recognize microbial products and 
induce the expression of hundreds of protein-coding genes 
involved in antimicrobial defense and adaptive immunity 
[91]. A recent study reveals that Toll-like receptors induce 
the expression of numerous lncRNAs. One of these, linc- 
RNA-Cox2, can mediate both activation and repression of 
distinct classes of immune genes, and the repressive effect 
is dependent on interactions of lincRNA-Cox2 with 
hnRNP-A/B and hnRNP-A2/B1 [92]. Collectively, these 
reports unveil a central role of lncRNAs as broad-acting 
regulators in immune response and host defense.  
3  Conclusion 
Results from large-scale analyses of transcriptome propose 
that tens of thousands of lncRNA are pervasively tran-
scribed from mammalian genomes. Moreover, even in some 
simple multicellular organisms, the amount of lncRNAs is 
far greater than that of the total small ncRNAs. We are only 
beginning to understand the realm of lncRNAs, whose rep-
resentation in the genome, according to comparative anal-
yses, increases with the increased genome complexity. The 
discovery that lncRNAs are central to numerous pivotal 
biological processes may reflect ancient connections be-
tween lncRNAs and the regulation of developmental and 
physiological decisions, whose disruption can lead to phys-
iological disorders as well as several types of diseases. 
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Some lncRNAs affect a great number of downstream targets. 
This raises a possibility that the adoption of lncRNAs per-
mits pathways to simultaneously regulate many aspects of a 
particular cellular process.   
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